THU-044 CCN5 promotes fibrogenic activation of hepatic stellate cells and serves as a biomarker for liver fibrosis
Yunhao Duan(Tongji University), Yuzhen Zhang, Carolin V. Schneider(RWTH Aachen University), Gang Zhao(Shanghai Jiao Tong University), Shougang Zhuang(Brown University), Hongda Li, Wenrun Wu(Shanghai East Hospital), Fan Ding(First People’s Hospital of Jingmen), Fangying Ji(Chongqing University), Jinnan Yue(Shanghai East Hospital), Frank Tacke(Charité - Universitätsmedizin Berlin), Jinjiang Pi, Lin Zhang(Mudanjiang Medical University), Qi Zhang(Peking University), Xiaoli Chen(Beijing Tian Tan Hospital), Yuting Zhang(Guilin Medical University), Jie Liu(Qingdao University), Christian Trautwein(TUM Klinikum), Bin Zhou(Tsinghua University), Kai Markus Schneider(University Hospital Carl Gustav Carus)
Cited by 0
Related Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.4k
Is a p53-Regulated Inhibitor of G2/M Progression
|Molecular Cell|1997|1.2k
Analysis of human transcriptomes
|Nature Genetics|1999|789